Charlie Rose Science Series Continues with Leading Experts in Longevity and Aging

Third Part of Science Series to Examine Longevity and the Aging Process

Co-hosted with Sir Paul Nurse, Nobel Laureate, President of Rockefeller

University



Mar 26, 2007, 01:00 ET from Charlie Rose Science Series

    NEW YORK, March 26 /PRNewswire/ -- Emmy Award winning journalist
 Charlie Rose announced the third installment of his 12-part Science Series
 examining the importance of scientific research in human health. This
 episode is an in- depth discussion of longevity and aging, including a look
 at existing and ongoing studies and the social and economic implications of
 an increase in human life span. Charlie's discussion includes experts who
 have contributed to important developments in the science of aging and how
 research into calorie restriction, anti-aging drugs, and genetic
 manipulation have led to exciting advances over the past decade.
     Special guests will include Dr. Richard Weindruch, University of
 Wisconsin; Dr. Robert Butler, President and CEO, International Longevity
 Center; Dr. Cynthia Kenyon; University of California-San Francisco; Dr. Jay
 Olshansky, University of Illinois-Chicago; and, Dr. Leonard Guarente, MIT.
 The program will air on more than 200 PBS stations across the country
 beginning on Wednesday, March 28th during Charlie's regularly scheduled
 program.
     "Longevity has reached something of a precipitating moment," said
 Charlie Rose. "It has become a subject of great interest for obvious
 reasons, and with great implications because the baby boom generation is
 moving forward. With a better understanding of the aging process, science
 will be able to assist the aging baby boomers, and improve on successes in
 fighting the diseases of aging."
     The Charlie Rose Science Series, which is sponsored by Pfizer Inc, is
 an exploration of the advances being made in scientific research, their
 contribution to our understanding of the world around us, and how these
 breakthroughs may be applied to improving human health. The series' first
 episode focused on the research and growing understanding of the human
 brain and the second episode examined the contributions that have been made
 to science through the discovering and mapping of human DNA.
     As the Baby Boom generation reaches retirement age and many older
 people live into their late 70s and beyond, the U.S. and global communities
 face tremendous challenges to health and economic security, quality of
 life, and the management of the diseases of aging. Across the world,
 scientists are conducting research to advance the field of longevity
 science, and address the close association between aging and diseases like
 Alzheimer's.
     According to a report released by the Alzheimer's Association on March
 20, 2007, there are more than five million people in the United States
 living with Alzheimer's disease. This number includes 4.9 million people
 over the age of 65, which translates into one out of eight people age 65
 and older and one out of every two people age 85 or older. It is estimated
 that by 2030, 7.7 million people will have Alzheimer's and by mid-century
 nearly 16 million will be affected.
     "While aging is the number one risk factor for Alzheimer's disease and
 the number of people with Alzheimer's continues to grow, the good news is
 that science is continuing to gain knowledge of how the disease works. This
 research has led to the effective treatments that are available today, and
 we expect it to lead to new treatments in the future that will address the
 underlying causes of Alzheimer's disease, thus allowing us to prevent it
 from developing or progressing," said Thomas McRae, M.D., of Pfizer. "We
 are committed to helping people live longer and healthier lives. To help
 fulfill that promise we are engaged in more research programs and clinical
 trials than at any other time in our history to develop the therapies that
 address this and other diseases of aging."
     Charlie Rose is joined in this series by his co-host, Sir Paul Nurse,
 PhD, Nobel Laureate and President of Rockefeller University.
     Speaking about the Charlie Rose Science Series, Dr. Nurse said, "Given
 the major impact that science has on every day life, it is necessary that
 we take the time to explain to the public how scientific advances and
 discoveries affect their daily lives. A proper understanding of how science
 will facilitate public debate on many of the important scientific questions
 such as aging and human longevity is increasingly important. I'm pleased to
 be involved with this effort, and I want to thank Pfizer for the promotion
 and support of the Science Series."
     For more information about The Charlie Rose Science Series or to watch
 clips from past episodes, please visit http://www.charlierose.com.
 
 

SOURCE Charlie Rose Science Series
    NEW YORK, March 26 /PRNewswire/ -- Emmy Award winning journalist
 Charlie Rose announced the third installment of his 12-part Science Series
 examining the importance of scientific research in human health. This
 episode is an in- depth discussion of longevity and aging, including a look
 at existing and ongoing studies and the social and economic implications of
 an increase in human life span. Charlie's discussion includes experts who
 have contributed to important developments in the science of aging and how
 research into calorie restriction, anti-aging drugs, and genetic
 manipulation have led to exciting advances over the past decade.
     Special guests will include Dr. Richard Weindruch, University of
 Wisconsin; Dr. Robert Butler, President and CEO, International Longevity
 Center; Dr. Cynthia Kenyon; University of California-San Francisco; Dr. Jay
 Olshansky, University of Illinois-Chicago; and, Dr. Leonard Guarente, MIT.
 The program will air on more than 200 PBS stations across the country
 beginning on Wednesday, March 28th during Charlie's regularly scheduled
 program.
     "Longevity has reached something of a precipitating moment," said
 Charlie Rose. "It has become a subject of great interest for obvious
 reasons, and with great implications because the baby boom generation is
 moving forward. With a better understanding of the aging process, science
 will be able to assist the aging baby boomers, and improve on successes in
 fighting the diseases of aging."
     The Charlie Rose Science Series, which is sponsored by Pfizer Inc, is
 an exploration of the advances being made in scientific research, their
 contribution to our understanding of the world around us, and how these
 breakthroughs may be applied to improving human health. The series' first
 episode focused on the research and growing understanding of the human
 brain and the second episode examined the contributions that have been made
 to science through the discovering and mapping of human DNA.
     As the Baby Boom generation reaches retirement age and many older
 people live into their late 70s and beyond, the U.S. and global communities
 face tremendous challenges to health and economic security, quality of
 life, and the management of the diseases of aging. Across the world,
 scientists are conducting research to advance the field of longevity
 science, and address the close association between aging and diseases like
 Alzheimer's.
     According to a report released by the Alzheimer's Association on March
 20, 2007, there are more than five million people in the United States
 living with Alzheimer's disease. This number includes 4.9 million people
 over the age of 65, which translates into one out of eight people age 65
 and older and one out of every two people age 85 or older. It is estimated
 that by 2030, 7.7 million people will have Alzheimer's and by mid-century
 nearly 16 million will be affected.
     "While aging is the number one risk factor for Alzheimer's disease and
 the number of people with Alzheimer's continues to grow, the good news is
 that science is continuing to gain knowledge of how the disease works. This
 research has led to the effective treatments that are available today, and
 we expect it to lead to new treatments in the future that will address the
 underlying causes of Alzheimer's disease, thus allowing us to prevent it
 from developing or progressing," said Thomas McRae, M.D., of Pfizer. "We
 are committed to helping people live longer and healthier lives. To help
 fulfill that promise we are engaged in more research programs and clinical
 trials than at any other time in our history to develop the therapies that
 address this and other diseases of aging."
     Charlie Rose is joined in this series by his co-host, Sir Paul Nurse,
 PhD, Nobel Laureate and President of Rockefeller University.
     Speaking about the Charlie Rose Science Series, Dr. Nurse said, "Given
 the major impact that science has on every day life, it is necessary that
 we take the time to explain to the public how scientific advances and
 discoveries affect their daily lives. A proper understanding of how science
 will facilitate public debate on many of the important scientific questions
 such as aging and human longevity is increasingly important. I'm pleased to
 be involved with this effort, and I want to thank Pfizer for the promotion
 and support of the Science Series."
     For more information about The Charlie Rose Science Series or to watch
 clips from past episodes, please visit http://www.charlierose.com.
 
 SOURCE Charlie Rose Science Series